The drug called Tofacitinib has been approved to treat adults with arthritis, but the number of cases in which the immune system can treat hair loss, which is the state of losing all the hair of the body to attack the hair follicles, is increasing I will. report.
According to Yale’s statement, this discovery occurred after a 25-year-old man complained of similar symptoms in mice to those with alopecia, this medicine was prescribed. After 3 months of treatment, I re-grown hair completely on the scalp and I could see eyebrows, eyelashes, facial hair, other hair of my body.
Mr. Dei who did not treat this special patient said it was “exciting.” “It seems that there is a real effect here”
It is unknown how Tofacitinib (brand name Xeljanz) works, but researchers hope to determine that mechanism soon. This data helps to know which biological pathways lead to hair loss.
Currently, clinical trials are conducted nationwide to test the safety and efficacy of alopecia drugs. One such study that lasted for 3 months gave Tofacitinib to 66 people with areas of alopecia (the immune system state where the hair follicles are spotted). According to the 2016 survey published in the JCI Insight journal, half of the people resumed their hair and one-third grew over 50% of the scalp.
However, researchers are still striving to determine the best results needed, whether the results persist and whether they can develop the local form of the drug, Day said. She added that the patient should notice that tofacitinib has side effects. According to manufacturer Pfizer, this already increases the risk of serious infection, tears in the stomach and intestines are also coming out.
In addition to Tofacitinib’s work, researchers are considering ways to clone hair or use stem cell therapy to treat alopecia, Day said.
The National Institutes of Health provides a way to deal with alopecia areata.
Read articles written by people with alopecia on the National Alopecia Areata Foundation.
At American Family Medicine Academy, we will learn about various types of depilation and diagnostic processes.